Stock-Based Compensation (Stock-Settled Stock Appreciation Rights Activity) (Details) (Stock Settled Stock Appreciation Rights SARS [Member], USD $) In Thousands, except Per Share data, unless otherwise specified	9 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Stock Settled Stock Appreciation Rights SARS [Member]
Number of Rights
Number of Rights, Outstanding at beginning of year (rights)	358
Number of Rights, Exercised (rights)	(54)
Number of Rights, Granted (rights)	149	146
Number of Rights, Forfeited (rights)	(31)
Number of Rights, Outstanding at end of period (rights)	422
Number of Rights, Exercisable and vested at end of period (rights)	154
Number of Rights, Vested and expected to vest at end of period (rights)	412
Weighted Average Exercise Price
Weighted Average Exercise Price, Outstanding at beginning of year (usd per share)	$ 76.75
Weighted Average Exercise Price, Exercised (usd per share)	$ 63.54
Weighted Average Exercise Price, Granted (usd per share)	$ 91.13
Weighted Average Exercise Price, Forfeited (usd per share)	$ 79.42
Weighted Average Exercise Price, Outstanding at end of period (usd per share)	$ 83.35
Weighted Average Exercise Price, Exercisable and vested at end of period (usd per share)	$ 74.70
Weighted Average Exercise Price, Vested and expected to vest at end of period (usd per share)	$ 83.35
Weighted Average Remaining Contractual Life in Years, Outstanding at end of period	3 years 8 months 23 days
Weighted Average Remaining Contractual Life in Years, Exercisable and vested at end of period	2 years 7 months 28 days
Weighted Average Remaining Contractual Life in Years, Vested and expected to vest at end of period	3 years 8 months 23 days
Aggregate Intrinsic Value, Outstanding at end of period	$ 4,984
Aggregate Intrinsic Value, Exercisable and vested at end of period	3,150
Aggregate Intrinsic Value, Vested and expected to vest at end of period	$ 4,873